Clinitech Laboratory Limited

About the company

## **About Clinitech Laboratory Limited** Founded in 1990, Clinitech Laboratory Limited operates a network of eight diagnostic centers strategically located in Thane and Navi Mumbai, offering a comprehensive range of diagnostic and healthcare tests. Annually, they conduct more than 3 lakh tests in their NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs, equipped with advanced technology and high-end equipment. These tests span across various disciplines including Biochemistry, Immunology, Hematology, Molecular Biology, Serology, Microbiology, and Histopathology, enabling precise diagnosis and effective treatment planning. Clinical pathology forms the core of their services, focusing on the analysis of bodily fluids and tissues to diagnose diseases and conditions. Their laboratories perform crucial tests such as blood tests, urine analysis, and tissue biopsies, which are essential in understanding the underlying causes of symptoms and guiding healthcare decisions. Their team of clinical pathologists plays a pivotal role in interpreting test results and providing valuable insights to aid in patient care. Looking ahead, they anticipate potential competition from new entrants with established business networks, posing threats to their market share. Such competitors may leverage larger financial resources for enhanced marketing and service delivery capabilities. Despite these challenges, Clinictech Laboratory Limited is poised to uphold its leadership in diagnostic and healthcare services through strategic management practices, technological innovation, and a steadfast commitment to meeting the evolving needs of their clientele. As Clinitech Laboratory Limited prepares for its Initial Public Offering (IPO), the proceeds from the Fresh Issue will be allocated towards critical objectives: 1. Expansion of Diagnostic Centres;  1. General Corporate Purposes

Financial performance (₹ Cr)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   25 Jul 2024

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   29 Jul 2024

   Last day to place your bid

3. Basis of Allotment

   Completed
   27 Jul 2024

   Share allotment finalised

4. Refund Initiation

   Completed
   31 Jul 2024

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   30 Jul 2024

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   01 Aug 2024

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.